Appreciation of osteoporosis among men with hyperparathyroidism

Endocrine Practice

Volumn 14, Issue 7, 2008, Pages 820-831

  Ballem, Naveen ^a   Greene, Andrew B ^a   Parikh, Rikesh T ^a   Berber, Eren ^a   Siperstein, Allan ^a   Milas, Mira ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN D;

ADOLESCENT; ADULT; AGED; ANATOMY; ARTICLE; BODY MASS; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONTROLLED STUDY; DEMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HIGH RISK POPULATION; HUMAN; INTRAOPERATIVE PERIOD; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATIENT REFERRAL; PHOSPHATE BLOOD LEVEL; PHYSICAL CAPACITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; SCANNING ELECTRON MICROSCOPY; SCREENING; SEX DIFFERENCE; BLOOD; HYPERPARATHYROIDISM; MIDDLE AGED; PHOTON ABSORPTIOMETRY;

ABSORPTIOMETRY, PHOTON; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; OSTEOPOROSIS; VITAMIN D;

EID: 64749095427     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.7.820     Document Type: Article

References (21)

1. Consensus development conference: Prophylaxis and treatment of osteoporosis. Am J Med. 1991;90:107-110.
2. Oden A, Dawson A, Dere W, Johnell O, Jonsson B, Kanis JA. Lifetime risk of hip fractures is underestimated. Osteoporos Int. 1998;8:599-603.
3. Nguyen TV, Eisman JA, Kelly PJ, Sambrook PN. Risk factors for osteoporotic fractures in elderly men. Am J Epidemiol. 1996;144:255-263.
4. Poór G, Atkinson EJ, O'Fallon WM, Melton LJ III. Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res. 1995;319:260-265.
5. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353:878-882.
6. Gennari L, Bilezikian JP. Osteoporosis in men. Endocrinol Metab Clin North Am. 2007;36:399-419.
7. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2003.
8. Miller PD. Management of osteoporosis. Dis Mon. 1999; 45:21-54.
9. Lal G, Clark OH. Diagnosis of primary hyperparathyroidism and indications for parathyroidectomy. In: Clark OH, Duh Q-Y, Kebebew E, eds. Textbook of Endocrine Surgery. 2nd ed. Philadelphia, PA: WB Saunders, 2005:384.
10. Anders M, Turner L, Wallace LS. Use of decision rules for osteoporosis prevention and treatment: implications for nurse practitioners. J Am Acad Nurse Pract. 2007;19: 299-305.
11. Bilezikian JP, Potts JT Jr, Fuleihan Gel-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-5361.
12. Abe Y, Ejima E, Fujiyama K, et al. Parathyroidectomy for primary hyperparathyroidism induces positive uncoupling and increases bone mineral density in cancellous bones. Clin Endocrinol (Oxf). 2000;52:203-209.
13. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery [erratum in N Engl J Med. 2000;342:144]. N Engl J Med. 1999;341:1249-1255.
14. Grant CS, Thompson G, Farley D, van Heerden J. Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg. 2005;140:472-478.
15. Ambrogini E, Cetani F, Cianferotti L, et al. Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial. J Clin Endocrinol Metab. 2007;92:3114-3121.
16. AACE/AAES Task Force on Primary Hyperparathyroidism. The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons position statement on the diagnosis and management of primary hyperparathyroidism. Endocr Pract. 2005;11:49-54.
17. Eigelberger MS, Cheah WK, Ituarte PH, Streja L, Duh QY, Clark OH. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg. 2004;239:528-535.
18. Perrier ND. Asymptomatic hyperparathyroidism: a medical misnomer? Surgery. 2005;137:127-131.
19. Binkley N. Osteoporosis in men. Arq Bras Endocrinol Metabol. 2006;50:764-774.
20. Haren MT, Kim MJ, Tariq SH, Wittert GA, Morley JE. Andropause: a quality-of-life issue in older males. Med Clin North Am. 2006;90:1005-1023.
21. Ockrim J, Lalani el-N, Abel P. Therapy insight: parenteral estrogen treatment for prostate cancer-a new dawn for an old therapy. Nat Clin Pract Oncol. 2006;3:552-563.